by John Conrad | Oct 10, 2024 | Member News
Vanqua Bio has announced positive interim results from its Phase 1 clinical trial of VQ-101, a novel drug designed to treat GBA-Parkinson’s and related disorders. This breakthrough could potentially slow or even halt the progression of Parkinson’s disease,...
by John Conrad | Aug 2, 2024 | iBIO News
NewsBrief Weekly News Quiz: August 2nd Friday Biotech Buzz: Weekly Knowledge Challenge 🧬🔬 Calling all life science aficionados! It’s time for our weekly iBIO NewsBrief Quiz. How well have you kept up with the latest breakthroughs? Let’s put your...
by John Conrad | Jul 26, 2024 | iBIO News
NewsBrief Weekly News Quiz: July 26th Friday Biotech Buzz: Weekly Knowledge Challenge 🧬🔬 Calling all life science aficionados! It’s time for our weekly iBIO NewsBrief Quiz. How well have you kept up with the latest breakthroughs? Let’s put your...
